Single-Cell Polyfunctional Strength Applied to Checkpoint & Antibody Based Immunotherapies
Discover how polyfunctional strength is making an impact with bispecifics and combination checkpoint therapies
Evaluate T cell responses induced by various bispecific T cell engagers across phenotypes
Understand the heterogeneity of TIL polyfunctionality in solid tumors in response to checkpoint inhibitors
Uniquely correlate clinical anti-tumor responses with IsoPlexis data